CanBas Co., Ltd. (TSE: 4575)
Health Care · Biotechnology · JP
¥802.00
+1.39% today · -40.5% 1Y
CanBas Co., Ltd. (TSE: 4575) operates in the Biotechnology industry within the Health Care sector. The company is valued at $96.42M and employs 14 people.
Over the last twelve months the share price has lost 40.5%, trading between 506.00 and 1.56K.
Tweenvest scores CanBas Co., Ltd. across four factors: quality 36/100. Its strongest factor is quality.
4575 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $96.42M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -66.39
- Dividend yield
- —
- Beta (5Y)
- -0.81
- 52-week high
- ¥1,558.00
- 52-week low
- ¥506.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.11M
- Employees
- 14
- Next earnings
- —
About CanBas Co., Ltd.
CanBas Co., Ltd. is a biopharmaceutical company in the clinical stage, dedicated to discovering and developing new therapies for cancer patients. Its main investigational compounds include CBP501, a calmodulin-modulating peptide aimed at treating various cancers, and CBS9106, a reversible exportin-1 inhibitor currently in Phase I clinical trials for solid tumors. The company also engages in a strategic partnership with Stemline Therapeutics, Inc. Established in Numazu, Japan, in 2000, CanBas Co., Ltd. continues its work in oncology.
- ISIN
- JP3244570002
- Founded
- 2000
- Listed since
- Sep 17, 2009
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.